[Latin Name]  Citrus aurantium L.

[Specification] Synephrine 4.0%–80%

[Appearance] Yellow brown powder

Plant Part Used: Fruit

[Particle size] 80Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

[What is Citrus Aurantium]

Citrus aurantium L, belonging to the family Rutaceae, is widely distributed in China. Zhishi, the Chinese traditional name for Citrus aurantium, has long been a folk medicine in traditional Chinese medicine (TCMto improve indigestion and help stimulate the Qi (energy force).

[Function]

1. Have the function of antioxidant, anti-inflammatory, hypolipidemic, vasoprotective and anticarcinogenic and cholesterol lowering actions.

2. Have the function of inhibiting following enzymes: Phospholipase A2, lipoxygenase, HMG-CoA reductase and cyclo-oxygenase.

3. Have the function of improving the health of capillaries by reducing the capillary permeability.

4. Have the function of reducing hay fever and other allergic conditions by inhibiting the release of histamine from mast cells. The possible activity of hesperidin could be explained by the inhibition of polyamine synthesis. (bitter orange extract)

Trà Xanh và Nấm Linh Chi là hai dược liệu quí trong tự nhiên giúp ngăn chặn tế bào ung thư, mà không làm tổn hại đến các tế bào lành.

Đây là một trong các video phóng sự được làm tại Đài Loan, ghi nhận các trường hợp thực tế đã điều trị thành công bệnh Ung thư bằng cách kết hợp các phương pháp hiện có với Cao Khô Linh Chi Đỏ Reishimax & Chiết Xuất Trà Xanh Tegreen’97. Reishimax và Tegreen97 là 2 sản phẩm đã được chứng minh hiệu quả tốt trên lâm sàng và đã được đưa vào danh mục thuốc điều trị tại liên bang Mỹ – The Federal Physical Desk Reference (PDR.net)

Bạn hãy chia sẻ cho thật nhiều người biết để giúp họ hoặc người thân có thêm phương pháp thiết thực thoát khỏi căn bệnh quái ác này nhé.

Để biết thêm chi tiết về cơ chế tác dụng xin vui lòng liên hệ qua email songtresongkhoe@gmail.com

More and more proofs of EGCG in green tea and Polysacchride in Lingzhi help killing maglinent cells but protect healthy cells.

This is one of video reports from Taiwan, about successful testimonials of different type cancer patients who applied a combine treatment of current oncology plus high concentrate red Ganoderma Lucidum mushroom (Reishimax) and green tea high concentrate (Tegreen’97). We can trust the safety and effectiveness of Reishimax & Tegreen97 as they are listed in The Federal Physical Desk Reference (PDR.net)

Please share to more friends and beloves to help them get rid of this devil disease

For more details on treatment and dosage please contact through email songtresongkhoe@gmail.com

(See https://nanohour.beckman.illinois.edu/Nanohour/Nanohour.html)

” A Tooth Problem: Biomodification of Dentin Matrices as Novel Strategy for Dental Therapies”

Prof. Ana Bedran-Russo (UIC College of Dentistry)

“It is estimated that in the United States, 350 million dental restorations
(fillings) are placed every year in dental offices. Sixty percent of those restorations
replace existing failed restorative treatments. The primary reason for failure of
dental restorations is secondary caries (decay), indicative of increased permeability
and debonding between tooth and restorative biomaterial. Current dental adhesive
restorative systems rely on the micromechanical retentions of restorations by
infiltrations of hydrophilic and hydrophobic resins into a collagen-rich surface on
dentin. Our laboratory at UIC has focused on understanding the tooth
biochemistry/biomechanics and explored biomimetic approaches for innovative
restorative/regenerative therapies. Specifically the interactions of olygomeric
proanthocyanidins agents (OPC) with dentin matrices to improve mechanical
properties and reduced biodegradation rates. This presentation will provide (1)
overview of challenges in the harsh oral environment (2) limitations of current
dental therapies and (3) mechanisms of interactions of OPC with type I collagen,
proteoglycans and matrix metalloproteinases (MMPs).”